sysa1901
Showing 1 - 1 of 1
HER2-positive Breast Cancer Trial in Shanghai (SYSA1901, Pertuzumab, Trastuzumab)
Recruiting
- HER2-positive Breast Cancer
- SYSA1901
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 8, 2023